Norinchukin Bank’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$39.6M Buy
506,283
+12,920
+3% +$1.01M 0.59% 28
2025
Q1
$35.8M Buy
493,363
+44,663
+10% +$3.24M 0.66% 28
2024
Q4
$33.2M Buy
448,700
+6,593
+1% +$488K 0.7% 27
2024
Q3
$29.2M Buy
442,107
+190,903
+76% +$12.6M 0.69% 29
2024
Q2
$23.2M Buy
251,204
+14,033
+6% +$1.3M 0.66% 30
2024
Q1
$22.7M Sell
237,171
-33,834
-12% -$3.23M 0.68% 30
2023
Q4
$20.7M Sell
271,005
-138,026
-34% -$10.5M 0.48% 33
2023
Q3
$28.3M Buy
409,031
+49,744
+14% +$3.45M 0.67% 26
2023
Q2
$33.9M Buy
359,287
+116,908
+48% +$11M 0.57% 28
2023
Q1
$20.1M Buy
+242,379
New +$20.1M 0.4% 41
2022
Q4
Sell
-47,652
Closed -$3.94M 550
2022
Q3
$3.94M Buy
47,652
+5,252
+12% +$434K 0.08% 155
2022
Q2
$4.03M Sell
42,400
-15,517
-27% -$1.48M 0.08% 151
2022
Q1
$6.82M Buy
57,917
+4,344
+8% +$511K 0.09% 132
2021
Q4
$6.94M Sell
53,573
-257
-0.5% -$33.3K 0.09% 128
2021
Q3
$6.09M Buy
53,830
+2,393
+5% +$271K 0.08% 134
2021
Q2
$5.33M Sell
51,437
-464
-0.9% -$48.1K 0.08% 135
2021
Q1
$4.34M Buy
51,901
+894
+2% +$74.8K 0.06% 147
2020
Q4
$4.65M Sell
51,007
-1,148
-2% -$105K 0.07% 135
2020
Q3
$4.16M Buy
52,155
+834
+2% +$66.6K 0.07% 137
2020
Q2
$3.55M Sell
51,321
-1,041
-2% -$71.9K 0.06% 146
2020
Q1
$3.29M Sell
52,362
-30,465
-37% -$1.92M 0.06% 140
2019
Q4
$6.44M Sell
82,827
-7,536
-8% -$586K 0.08% 141
2019
Q3
$6.62M Buy
90,363
+2,202
+2% +$161K 0.09% 142
2019
Q2
$5.43M Sell
88,161
-30,156
-25% -$1.86M 0.08% 148
2019
Q1
$7.55M Buy
118,317
+3,465
+3% +$221K 0.1% 143
2018
Q4
$5.86M Buy
114,852
+34,056
+42% +$1.74M 0.08% 154
2018
Q3
$4.69M Buy
80,796
+9,156
+13% +$531K 0.06% 158
2018
Q2
$3.48M Buy
71,640
+13,908
+24% +$675K 0.05% 181
2018
Q1
$2.69M Buy
57,732
+6,975
+14% +$324K 0.04% 191
2017
Q4
$1.91M Buy
50,757
+3,606
+8% +$135K 0.03% 251
2017
Q3
$1.72M Buy
47,151
+3,474
+8% +$127K 0.03% 284
2017
Q2
$1.72M Buy
43,677
+2,250
+5% +$88.7K 0.04% 271
2017
Q1
$1.3M Buy
41,427
+2,511
+6% +$78.7K 0.03% 303
2016
Q4
$1.22M Buy
38,916
+4,725
+14% +$148K 0.03% 294
2016
Q3
$1.37M Buy
34,191
+873
+3% +$35.1K 0.03% 270
2016
Q2
$1.11M Buy
33,318
+279
+0.8% +$9.28K 0.03% 282
2016
Q1
$971K Buy
33,039
+2,808
+9% +$82.5K 0.02% 310
2015
Q4
$796K Sell
30,231
-6,675
-18% -$176K 0.02% 319
2015
Q3
$874K Buy
36,906
+366
+1% +$8.67K 0.02% 334
2015
Q2
$867K Sell
36,540
-1,818
-5% -$43.1K 0.02% 341
2015
Q1
$911K Sell
38,358
-54,954
-59% -$1.31M 0.02% 345
2014
Q4
$1.98M Buy
93,312
+53,052
+132% +$1.13M 0.05% 192
2014
Q3
$685K Buy
40,260
+16,644
+70% +$283K 0.02% 270
2014
Q2
$338K Sell
23,616
-3,012
-11% -$43.1K 0.01% 383
2014
Q1
$329K Buy
26,628
+2,106
+9% +$26K 0.01% 408
2013
Q4
$269K Sell
24,522
-780
-3% -$8.56K 0.01% 418
2013
Q3
$294K Buy
25,302
+1,824
+8% +$21.2K 0.01% 394
2013
Q2
$263K Buy
+23,478
New +$263K 0.01% 370